Minimally invasive neurosurgery devices market to grow between 2015 and 2025 — 6 takeaways

Written by Megan Wood | November 10, 2016 | Print  |

The global minimally invasive neurosurgery devices market is expected to grow through 2025, according to a Future Market Insights report.

Here are six takeaways:


1. The aging population and increasing number of neurological disorder cases will spur market growth in the forecast period.


2. A dearth of skilled professionals in developing countries as well as unfavorable reimbursements will hinder the market.


3. Currently, North America dominates the market, because of the high neurosurgical case volume in this region.


4. Europe follows North America in market share, because of its technological advancements in the healthcare industry.


5. The Asia-Pacific region is anticipated to grow, due to market opportunity in India and China.


6. Key market players include:

• Karl Storz GmbH & Co. in Tuttlingen, Germany
• Olympus Corp. in Center Valley, Pa.
• Conmed Corp. in Utica, N.Y.
• Richard Wolf in Vernon Hills, Ill.
• Boston Scientific in Rolling Meadows, Ill.
• Integra LifeSciences Holdings Corp. in Plainsboro, N.J.
• Aesculap in Center Valley, Pa.
• Smith & Nephew in London, U.K.
• Medtronic in Dublin, Ireland
• NICO Corp. in Carmel, Ind.


More articles on devices:
Watchdog told Medicare and Medicaid EpiPen was improperly classified in 2009: 4 things to know
Globus Medical reports Q3 revenue of $135.7M — 5 highlights
University of Iowa Hospitals and Clinics joins InVivo Therapeutics' INSPIRE Study: 5 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers